1887

Journal of General Virology header logo

Volume 93, Issue 8

Polymorphisms in Toll-like receptor 3 confer natural resistance to human herpes simplex virus type 2 infection Free

Abstract

Lack of Toll-like receptor 3 (TLR3) functional activity predisposes children to human herpesvirus 1 (HSV-1) encephalitis. In this study, we have investigated whether there is any link between TLR3 and adult HSV-2 infection by studying genetic variations in TLR3. The frequency of four single-nucleotide polymorphisms (SNPs) in the gene in 239 patients with genital HSV-2 infection and 162 healthy controls, as well as the impact of these variants on gene-expression levels, were compared. Two SNPs in the gene (rs13126816 and rs3775291) were associated with a reduced incidence of HSV-2 infection. The minor allelic variants at both rs13126816 and rs3775291 were more common among healthy HSV-2-seronegative subjects than among HSV-2-infected individuals. This was even more apparent in HSV-1-seronegative individuals. There was, however, no association between any of the four TLR3 SNPs and HSV-2 disease severity, as they were expressed at similar proportions in asymptomatic and symptomatic HSV-2-infected patients alike. Furthermore, when assessing TLR3 mRNA expression in a limited number of HSV-2-infected individuals, we found that individuals carrying the homozygous genotypes for the minor alleles had significantly higher levels of TLR3 mRNA expression in peripheral blood mononuclear cells in response to HSV-2 stimulation than individuals that were homozygous for the major allele variants. Taken together, these results suggest that genetic variations in may affect the susceptibility to HSV-2 infection in humans.

  • Received:
  • Accepted:
  • Published Online:
© 2012 SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.042572-0
2012-08-01
2024-04-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/93/8/1717.html?itemId=/content/journal/jgv/10.1099/vir.0.042572-0&mimeType=html&fmt=ahah

References

  1. Aldener-Cannavá A., Olerup O. 1996; HLA-DPA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) and distribution of DPA1 alleles in Caucasian, African and Oriental populations. Tissue Antigens 48:153–160
     [Google Scholar]
  2. Andersen J. M., Al-Khairy D., Ingalls R. R. 2006; Innate immunity at the mucosal surface: role of Toll-like receptor 3 and Toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens. Biol Reprod 74:824–831 [View Article][PubMed]
     [Google Scholar]
  3. Barrett J. C., Fry B., Maller J., Daly M. J. 2005; Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265 [CrossRef]
     [Google Scholar]
  4. Berntsson M., Tunbäck P., Ellström A., Krantz I., Löwhagen G. B. 2009; Decreasing prevalence of herpes simplex virus-2 antibodies in selected groups of women in Sweden. Acta Derm Venereol 89:623–626 [View Article][PubMed]
     [Google Scholar]
  5. Bochud P. Y., Magaret A. S., Koelle D. M., Aderem A., Wald A. 2007; Polymorphisms in TLR2 are associated with increased viral shedding and lesional rate in patients with genital herpes simplex virus type 2 infection. J Infect Dis 196:505–509 [View Article][PubMed]
     [Google Scholar]
  6. Casrouge A., Zhang S. Y., Eidenschenk C., Jouanguy E., Puel A., Yang K., Alcais A., Picard C., Mahfoufi N. other authors 2006; Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314:308–312 [View Article][PubMed]
     [Google Scholar]
  7. Davey G. M., Wojtasiak M., Proietto A. I., Carbone F. R., Heath W. R., Bedoui S. 2010; Cutting edge: priming of CD8 T cell immunity to herpes simplex virus type 1 requires cognate TLR3 expression in vivo. J Immunol 184:2243–2246 [View Article][PubMed]
     [Google Scholar]
  8. Eriksson K., Bellner L., Görander S., Löwhagen G. B., Tunbäck P., Rydberg K., Liljeqvist J. A. 2004; CD4+ T-cell responses to herpes simplex virus type 2 (HSV-2) glycoprotein G are type specific and differ in symptomatic and asymptomatic HSV-2-infected individuals. J Gen Virol 85:2139–2147 [View Article][PubMed]
     [Google Scholar]
  9. Forsgren M., Skoog E., Jeansson S., Olofsson S., Giesecke J. 1994; Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: implications for STD epidemiology. Int J STD AIDS 5:113–116[PubMed]
     [Google Scholar]
  10. Guo Y., Audry M., Ciancanelli M., Alsina L., Azevedo J., Herman M., Anguiano E., Sancho-Shimizu V., Lorenzo L. other authors 2011; Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity. J Exp Med 208:2083–2098 [View Article][PubMed]
     [Google Scholar]
  11. Herbst-Kralovetz M. M., Pyles R. B. 2006; Quantification of poly(I : C)-mediated protection against genital herpes simplex virus type 2 infection. J Virol 80:9988–9997 [View Article][PubMed]
     [Google Scholar]
  12. Kawai T., Akira S. 2006; Innate immune recognition of viral infection. Nat Immunol 7:131–137 [View Article][PubMed]
     [Google Scholar]
  13. Kindberg E., Vene S., Mickiene A., Lundkvist A., Lindquist L., Svensson L. 2011; A functional Toll-like receptor 3 gene (TLR3) may be a risk factor for tick-borne encephalitis virus (TBEV) infection. J Infect Dis 203:523–528 [View Article][PubMed]
     [Google Scholar]
  14. Langenberg A. G., Corey L., Ashley R. L., Leong W. P., Straus S. E. Chiron HSV Vaccine Study Group 1999; A prospective study of new infections with herpes simplex virus type 1 and type 2. N Engl J Med 341:1432–1438 [View Article][PubMed]
     [Google Scholar]
  15. Lekstrom-Himes J. A., Hohman P., Warren T., Wald A., Nam J. M., Simonis T., Corey L., Straus S. E. 1999; Association of major histocompatibility complex determinants with the development of symptomatic and asymptomatic genital herpes simplex virus type 2 infections. J Infect Dis 179:1077–1085 [View Article][PubMed]
     [Google Scholar]
  16. Matsumoto M., Kikkawa S., Kohase M., Miyake K., Seya T. 2002; Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem Biophys Res Commun 293:1364–1369 [View Article][PubMed]
     [Google Scholar]
  17. Miettinen M., Sareneva T., Julkunen I., Matikainen S. 2001; IFNs activate Toll-like receptor gene expression in viral infections. Genes Immun 2:349–355 [View Article][PubMed]
     [Google Scholar]
  18. Miyake T., Kumagai Y., Kato H., Guo Z., Matsushita K., Satoh T., Kawagoe T., Kumar H., Jang M. H. other authors 2009; Poly I : C-induced activation of NK cells by CD8α+ dendritic cells via the IPS-1 and TRIF-dependent pathways. J Immunol 183:2522–2528 [View Article][PubMed]
     [Google Scholar]
  19. Oshiumi H., Matsumoto M., Funami K., Akazawa T., Seya T. 2003; TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction. Nat Immunol 4:161–167 [View Article][PubMed]
     [Google Scholar]
  20. Pérez de Diego R., Sancho-Shimizu V., Lorenzo L., Puel A., Plancoulaine S., Picard C., Herman M., Cardon A., Durandy A. other authors 2010; Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity 33:400–411 [View Article][PubMed]
     [Google Scholar]
  21. Persson K., Månsson A., Jönsson E., Nordenfelt E. 1995; Decline of herpes simplex virus type 2 and Chlamydia trachomatis infections from 1970 to 1993 indicated by a similar change in antibody pattern. Scand J Infect Dis 27:195–199 [View Article][PubMed]
     [Google Scholar]
  22. Ranjith-Kumar C. T., Miller W., Sun J., Xiong J., Santos J., Yarbrough I., Lamb R. J., Mills J., Duffy K. E. other authors 2007; Effects of single nucleotide polymorphisms on Toll-like receptor 3 activity and expression in cultured cells. J Biol Chem 282:17696–17705 [View Article][PubMed]
     [Google Scholar]
  23. Reinert L. S., Harder L., Holm C. K., Iversen M. B., Horan K. A., Dagnæs-Hansen F., Ulhøi B. P., Holm T. H., Mogensen T. H. other authors 2012; TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice. J Clin Invest 122:1368–1376 [View Article][PubMed]
     [Google Scholar]
  24. Seppänen M., Lokki M. L., Lappalainen M., Hiltunen-Back E., Rovio A. T., Kares S., Hurme M., Aittoniemi J. 2009; Mannose-binding lectin 2 gene polymorphism in recurrent herpes simplex virus 2 infection. Hum Immunol 70:218–221 [View Article][PubMed]
     [Google Scholar]
  25. Singh R., Kumar A., Creery W. D., Ruben M., Giulivi A., Diaz-Mitoma F. 2003; Dysregulated expression of IFN-γ and IL-10 and impaired IFN-γ-mediated responses at different disease stages in patients with genital herpes simplex virus-2 infection. Clin Exp Immunol 133:97–107 [View Article][PubMed]
     [Google Scholar]
  26. Sironi M., Biasin M., Cagliani R., Forni D., De Luca M., Saulle I., Lo Caputo S., Mazzotta F., Macías J. other authors 2012; A common polymorphism in TLR3 confers natural resistance to HIV-1 infection. J Immunol 188:818–823 [View Article][PubMed]
     [Google Scholar]
  27. Svensson A., Bergin A. M., Löwhagen G. B., Tunbäck P., Bellner L., Padyukov L., Eriksson K. 2008; A 3′-untranslated region polymorphism in the TBX21 gene encoding T-bet is a risk factor for genital herpes simplex virus type 2 infection in humans. J Gen Virol 89:2262–2268 [View Article][PubMed]
     [Google Scholar]
  28. Vercammen E., Staal J., Beyaert R. 2008; Sensing of viral infection and activation of innate immunity by Toll-like receptor 3. Clin Microbiol Rev 21:13–25 [View Article][PubMed]
     [Google Scholar]
  29. Weiss H. 2004; Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes 11:Suppl. 124A–35A[PubMed]
     [Google Scholar]
  30. Willmann O., Ahmad-Nejad P., Neumaier M., Hennerici M. G., Fatar M. 2010; Toll-like receptor 3 immune deficiency may be causative for HSV-2-associated Mollaret meningitis. Eur Neurol 63:249–251 [View Article][PubMed]
     [Google Scholar]
  31. Yamamoto M., Sato S., Mori K., Hoshino K., Takeuchi O., Takeda K., Akira S. 2002; Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling. J Immunol 169:6668–6672[PubMed] [CrossRef]
     [Google Scholar]
  32. Zhang S. Y., Jouanguy E., Ugolini S., Smahi A., Elain G., Romero P., Segal D., Sancho-Shimizu V., Lorenzo L. other authors 2007; TLR3 deficiency in patients with herpes simplex encephalitis. Science 317:1522–1527 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.042572-0
Loading
Polymorphisms in Toll-like receptor 3 confer natural resistance to human herpes simplex virus type 2 infection
J. Gen. Virol. 93, 1717 (2012); https://doi.org/10.1099/vir.0.042572-0
/content/journal/jgv/10.1099/vir.0.042572-0
/content/journal/jgv/10.1099/vir.0.042572-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error